Vascular Complications in Patients Undergoing Peripheral Revascularization and Taking SGLT-2 Inhibitors

NCT07157475 · clinicaltrials.gov ↗

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Arterial Disease(PAD)

Interventions

DRUG: Treatment with SGLT2 inhibitors (flozins)

Sponsor

Wroclaw Medical University

Collaborators

[object Object]
[object Object]